Next Article in Journal
Neurological symptoms due to Coronavirus disease 2019
Previous Article in Journal
Parkinson’s disease prevalence, age distribution and staging in Colombia
 
 
Neurology International is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical features of hemichoreahemiballism: A stroke-related movement disorder

1
Course of Neurology, Department of Health Sciences, Tsukuba University of Technology; 2Department of Neurology, Tsukuba Memorial Hospital
2
Department of Neurology, Tsukuba Memorial Hospital
3
Primary Care and Medical Education, Graduate School of Comprehensive Human Sciences, University of Tsukuba
4
Department of Neurology, Graduate School of Comprehensive Human Science, University of Tsukuba
5
Course of Neurology, Department of Health Sciences, Tsukuba University of Technology; Department of Radiological Technology, Tsukuba International University
*
Author to whom correspondence should be addressed.
Neurol. Int. 2020, 12(1), 8328; https://doi.org/10.4081/ni.2020.8328
Submission received: 30 September 2019 / Revised: 30 September 2019 / Accepted: 30 September 2019 / Published: 10 July 2020

Abstract

We examined pathogenesis and clinical features of three hemichorea-hemiballism (HCHB) cases. We studied their age, magnetic resonance imaging results, vascular risk factors, management, and outcomes. One man and two women (aged 74-86 years) demonstrated acute onset of HCHB, lasting for at least several months. Patients had one or more vascular risk factors, including hypertension and diabetes. All patients presented subacute or old infarction in the basal ganglia with contralateral symptoms. We administered clonazepam (0.5-1 mg/day), haloperidol (0.375-0.75 mg/day), or both as necessary and observed symptom-control. Vascular lesions in the basal ganglia were a contributing factor. Symptoms were controlled using pharmacotherapy with gamma-aminobutyric acid-agonist (clonazepam) or anti-dopaminergic (haloperidol) medication.
Keywords: Hemichorea-hemiballism; Strokerelated movement disorders; basal ganglia Hemichorea-hemiballism; Strokerelated movement disorders; basal ganglia

Share and Cite

MDPI and ACS Style

Shiraiwa, N.; Hoshino, S.; Saito, G.; Tamaoka, A.; Ohkoshi, N. Clinical features of hemichoreahemiballism: A stroke-related movement disorder. Neurol. Int. 2020, 12, 8328. https://doi.org/10.4081/ni.2020.8328

AMA Style

Shiraiwa N, Hoshino S, Saito G, Tamaoka A, Ohkoshi N. Clinical features of hemichoreahemiballism: A stroke-related movement disorder. Neurology International. 2020; 12(1):8328. https://doi.org/10.4081/ni.2020.8328

Chicago/Turabian Style

Shiraiwa, Nobuko, Sachiko Hoshino, Go Saito, Akira Tamaoka, and Norio Ohkoshi. 2020. "Clinical features of hemichoreahemiballism: A stroke-related movement disorder" Neurology International 12, no. 1: 8328. https://doi.org/10.4081/ni.2020.8328

Article Metrics

Back to TopTop